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Abbreviations 
CAMHS Children’s and Adolescents’ Mental Health Services 
DSM Diagnostic and Statistical Manual 
FND Functional Neurological Disorder 
ICD International Classification of Diseases 
IDACI Income Deprivation Affecting Children Index, part of IMD 
IMD Index of Multiple Deprivation (see text) 
NHS (UK) National Health Service 
NTW Northumberland Tyne & Wear NHS Foundation Trust (a provider of 
 specialist paediatric mental health services (CAMHS: see text) 
NUTH Newcastle upon Tyne Hospitals NHS Trust (a University Hospital providing  
 adult and paediatric medical services: see text) 
 
 
What’s known on this subject 
Functional Neurological Disorder (FND) is a major challenge in both paediatric and adult 
neurological practice.  
Although reported short term outcomes after paediatric FND have been encouraging, very 
little is known about long term outcomes  
What this study adds 
The incidence of paediatric FND is higher than previously reported, due to co-occurrence of 
FND with conventional neurological disease (especially epilepsy).  
Even in a selected population of children reaching specialist paediatric neurology services a 
high long-term symptom remission rate is seen 
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Abstract 
Objectives 
To establish the incidence and long-term outcomes (up to 21 years) of children presenting to 
a University hospital paediatric neurology service with symptoms due to functional 
neurological disorder (FND) with particular reference to occurrence of FND or similar 
symptoms in adulthood 
Methods 
Retrospective chart review to determine characteristics of the original paediatric FND 
presentation plus record-linkage with providers of Child and Adolescent Mental Health 
Services (CAMHS). Chart review of adult medical records for documentation of functional 
symptoms in adulthood  
Results 
124 individuals (56% female) met entry criteria. The most common presentations were 
seizures (18% ), sensory loss (18%) and motor symptoms (16%). Frequency gradually 
increased with age of onset with an incidence in paediatric neurological services of 6 per 
100,000 children under 16. In up to 21 years’ follow-up (median 8.3 years), 114/124 attained 
their 16th birthdays by the study census date and were thus eligible for inclusion in an 
analysis of symptom persistence/recurrence in adulthood. 26/114 (23%) showed evidence of 
FND in adulthood of sufficient significance to be recorded in medical records.  
Conclusion 
Paediatric FND is commoner than previous estimates. Even in this selected population of 
children reaching specialist paediatric neurology services a high long-term remission rate is 
observed.  
  
Introduction 
 
Functional Neurological Disorder (FND) is a diagnostic term for the various ways in which 
patients experience abnormalities of nervous system functioning that are internally 
inconsistent, or incongruous with recognised brain pathology. Past, mostly less constructive 
synonyms have included “hysterical”, “conversion”, “psychogenic”, “non-organic”, 
“medically-unexplained”, “dissociative” and “somatoform” symptoms. FND is common in 
adults: responsible for 7-15% and playing a role in up to a third of all new referrals to adult 
neurology clinics1-3. FND can be reliably diagnosed by the presence of positive, characteristic 
clinical features: it is not merely a diagnosis of exclusion, turned to as organic causes for 
symptoms are eliminated4,5.  
 
Although there has been some research into general functional symptoms in childhood there 
has been little specific focus on paediatric functional neurological symptoms. Lieb et al. 
found 12.5% of 14-24 year olds reporting “general somatoform symptoms”6. Using a 
surveillance approach, Ani et al7 reported an incidence for “conversion disorder” of 
1.30/100,000 children under 16 years of age. Their case definition is one that will have 
emphasised neurological presentations. They found an incidence of 0.26/100,000 in children 
under 10 and 3.04/100,000 in 10-15 year olds and a 3:1 female to male ratio in both age 
groups7. Kozlowska et al estimated an incidence of 2.3-4.2/100,000 of “conversion disorder” 
presenting to paediatricians: again neurological symptoms predominated although other 
presentations were seen8. 
 
Prognosis in adult FND is guarded, with remission rates for motor and seizure symptoms of 
21% and 40% respectively9. Corresponding outcome data in paediatric FND is limited 
although short-term outcome appears reasonably favourable7,10,11. Reported symptom 
freedom rates after non-epileptic seizures in children vary widely from 23-72%12. The limited 
longer-term outcome data however is less sanguine. Jans et al.13 reported late outcomes in a 
selected cohort of children with dissociative symptoms (mean age at presentation 11.7 years) 
with 83% meeting criteria for various psychiatric diagnoses and 26% still suffering 
dissociative symptoms 12 years later. A Finnish study found strong correlation between 
frequent reporting of somatoform symptoms in teenagers (mean age 16.8 years) and 
continued reporting of those symptoms five years later14 
 
Prolonged duration of symptoms and delayed recognition of their functional nature emerge as 
negative prognostic factors in adult studies15. This suggests that adults with FND symptoms 
that have persisted since childhood may be a particularly challenging group to help. Thus we 
hypothesise that an improved understanding of factors associated with persistence and/or 
relapse of FND after paediatric presentations may have relevance to the study of FND at all 
ages.  
 
In this study we examine late outcomes (up to 21 years) after paediatric presentations of FND 
to a single University Hospital paediatric neurology service.  
  
Methods 
Case ascertainment 
Index cases were identified from a diagnostic database maintained in Newcastle of all in- and 
out-patients seen by the Paediatric Neurology service at the Newcastle upon Tyne Hospitals’ 
NHS Foundation Trust (NUTH) since 1997. Up to five diagnosis fields are available for each 
patient in the database and ICD-10 is used as the coding system. Coding was performed 
prospectively by RF throughout this period. The Service sees tertiary referrals from an area of 
northern England with a under 16 population in 2011 of 601,26316. The same hospital is the 
sole hospital provider of adult medical services (including neurology) to a geographically 
smaller area around Newcastle. To minimise the potential for bias due to more 
straightforward adult functional presentations elsewhere in the region being seen and 
managed locally and thus absent from adult NUTH records, we selected children resident at 
presentation in a restricted area around the hospital comprising Newcastle, Northumberland, 
and North Tyneside (with a combined under-16 population in 2011 of 137,553). 
 
The primary sample therefore comprised all children in the database with one or more of their 
up to five ICD-10 diagnoses in the range F44.x (“Dissociative [conversion] disorders”), 
F45.x (“Somatoform disorders”) or F48.x (“Other neurotic disorders”: including 
“neurasthenia” and “de-personalisation-derealization syndrome”); resident in Newcastle, 
Northumberland, or North Tyneside; presenting between 1st February 1997 and 31st 
December 2017. 
 
Baseline Data extraction 
Data relating to the initial FND presentation were extracted via chart review by JR. Age at 
symptom onset and time from symptom onset to recognition of the FND diagnosis, gender, 
details of initial presentation and presence of any co-morbidities were recorded. Where 
multiple symptoms were present a “dominant” symptom was identified by JR based on the 
primary presenting complaint and/or the symptom causing greatest limitation. Family 
socioeconomic status was inferred using the Income Deprivation Affecting Children Index 
(IDACI)17, a locality deprivation score combining census-derived indicators of income, 
employment, health, and disability calculated from the family postcode at the time of 
presentation. 
 
Two raters (JR and VC) independently coded “nature of explanation offered for symptoms” 
and “parental acceptance of proposed functional nature of symptoms” using the classification 
in   
Table 2. Coding discrepancies were reconciled by discussion.  
 
Follow-up methods 
The NUTH medical records for these individuals subsequent to the FND presentation were 
examined by a single rater (JR) for any evidence of contact with adult medical services for 
FND or a functional disorder affecting any another body system, prior to a census date of 31st 
December 2017. Such contact was defined as “relapse” and was the primary endpoint for 
statistical analyses. 
 
Additionally, we undertook a record linkage study with Northumberland, Tyne & Wear NHS 
Foundation Trust (NTW), the provider of mental health services to the same geographic 
population, to allow identification of involvement with NTW Children’s and Adolescents’ 
Mental Health Services (CAMHS) and start and end dates of such involvement. Contact with 
CAMHS was coded as “before” (CAMHS involvement had ended prior to the diagnosis of 
FND), “after” (CAMHS involvement commenced subsequent to diagnosis of FND), 
“spanning” (began before and continued after diagnosis of FND), or as “no record of 
involvement”. 
 
Statistical analysis 
A right-censored, left-truncated Cox proportional-hazard model was used to determine 
factors associated with presentation to adult medical services with FND with cases being 
informative once they were over 16, using a censor date of 31st December 2017. Cox 
proportional-hazard models are well-suited to left-truncated data, necessary here as children 
could only become cases capable of “relapsing” (i.e. presenting to adult services) once they 
were 16. All potentially relevant clinical data reliably and widely ascertainable from clinical 
notes were used as independent variables in the model. Survival analysis was performed 
using the survival library18 in R19 and all other analysis performed in R. Standard methods 
were used for the calculation of inter-rater reliability20, Kruskall-Wallis21 and Pearson chi-
squared tests22. 
 
Ethics 
Regulatory approvals were sought for both the notes review of former patients, and the 
record-linkage to be completed without explicit informed consent from past patients. This 
was felt to be important as (i) contacting patients many years after diagnosis, who may not 
self-identify as having experienced FND was regarded as potentially psychologically 
harmful; and (ii) there was a major risk of bias if only records of individuals giving explicit 
consent were available. Support for this position came from a public consultation exercise 
conducted with the help of FND Action, a UK patient support organisation for individuals 
affected by FND (www.fndaction.org.uk). In an online survey (n = 42 responses) 80% 
strongly or somewhat agreed with the study design and its rationale. Approvals were granted 
by the North East Newcastle & North Tyneside 1 Research Ethics Committee (reference 
16NE0401) and the national Confidentiality Advisory Group of the NHS Health Research 
Authority (reference 17/CAG/0047).  
  
Results 
 
Baseline data 
 
124 individuals (70 female) met study criteria, an incidence of 6.0/100,000 children under 16 
(see Discussion). Characteristics are shown in  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
Figure 1 and Table 1. FND became gradually more common with increasing age of onset 
such that the modal age of onset was 16 years. Non-epileptic seizures were the commonest 
presentation (41%) followed by sensory loss (18%), motor symptoms (predominantly limb 
weakness: 16%), pain (11%) and other (14%). A minority of presentations (13/124) were 
poly-symptomatic, the commonest combination being of pain with sensory loss (n = 6). In 
these cases, the dominant symptom was recorded. There was no statistically significant 
association between presentation symptom group and sex (p>0.4) (Figure 2). In 18 cases a 
precipitating organic “trigger” for the FND presentation could be identified (minor injury in 
5, syncope in 5, migraine in 3, other in 4) however since absence of such documentation 
could not be assumed to be documentation of absence, this factor could not be used in 
subsequent analysis.  
 Neurological co-morbidities were common (Table 1). In those in whom other neurological 
diagnoses were considered (usually at other centres) before a functional diagnosis was made 
(n = 44), epilepsy was by far the commonest (Table 1): the “other” group here comprised 
often-tentative diagnoses made in other centres (usually in single cases) including 
neuropraxis, Alice in Wonderland syndrome, cervical rib, paroxysmal extreme pain 
syndrome, and optic neuritis. Chronic non-neurological medical conditions (hypermobility, 
asthma, diabetes, arthritis etc) were present in 16 children (data not shown). 
 
Consensus codings for the explanation model provided and parental acceptance are shown in   
Table 2. The inter-rater kappa reliability statistics20 for the independent ratings of these two 
variables were 0.81 and 0.71 respectively indicating substantial agreement. There was 
insufficient data available in the medical records to categorise “explanation given” for n = 9 
and “parental response” for n = 58 cases. There was no statistically significant association 
between these two factors (i.e. no evidence that particular explanation models were 
associated with greater parental acceptance; p >0.3 after combining the first with second and 
third with fourth parental response categories to address small numbers).  
 
Time to diagnosis (the interval from symptom onset, which sometimes had to be estimated, to 
the point at which a functional diagnosis was made) was highly skewed and ranged from 0 – 
1866 days (median 200, IQR 83-413 days) (Table 1). Although the majority of the very long 
diagnostic delays were situations of non-epileptic seizures developing on a background of 
established epilepsy, associations between symptom group and time to diagnosis did not 
reach statistical significance (Kruskal-Wallis rank sum; p = 0.86). There was however 
evidence of longer times to diagnosis for females (median, range and interquartile range 240, 
11-1866, 96-605 days) than males (152, 0-708, 52-392 days) (Kruskal-Wallis rank sum; p = 
0.048). Time to diagnosis was greater in the “hostile” than in other parental response groups 
(Kruskal-Wallis rank sum; p = 0.028) although the direction of causality here cannot be 
established: parental distress may be a result of delayed diagnosis. 
 
 
Follow up data 
 
Initial follow up practices within the paediatric neurology service varied widely with periods 
of active ongoing neurological involvement after diagnosis of FND ranging from 0-74 
months (median 3.4, IQR 0-14 months). A wide variety of other services (clinical 
psychology, physiotherapy, pain team, other medical specialties) were typically involved 
during this time. The more rapid discharges typically reflected transfer back to secondary 
paediatric or mental health services for ongoing management after confirmation of a 
diagnosis of FND. Roughly a third (40/124) of cases were deemed to be in remission at the 
time of discharge from paediatric neurology. There was no statistically significant association 
between presenting symptom group and either duration of follow up with, or remission at 
discharge from, paediatric neurology services (data not shown). Commonest referral 
destinations for ongoing support were general (secondary) paediatrics (n = 24), and clinical 
psychology (n = 28). Decisions as to whether refer on for more substantial CAMHS support 
were at treating clinicians’ and clinical psychologists’ discretion. 
 
We found documentation of CAMHS involvement for 64/124 patients. 6/124 had had 
CAMHS contact that had ended before the FND diagnosis and had not continued afterward. 
25/124 had confirmed involvement only after their FND was diagnosed. 33/124 had 
documented involvement that had commenced before and continued after the FND diagnosis. 
There was no documentation of CAMHS involvement for 60/124. For patient confidentiality 
reasons we did not seek to access primary CAMHS medical records.  
 
114 of 124 individuals were over 16 on 31st December 2017 and thus potentially able to 
present to adult medical services. Evidence of contact with adult medical services with 
functional symptoms was found for n = 26/114 (23%). 18/26 presented with a relapse of the 
same symptom(s) exhibited in childhood. 8/26 presented with a different symptom. Two with 
previous subjective sensory symptoms developed non-epileptic attacks or collapses. One with 
previous non-epileptic attacks developed functional visual loss, and another vice versa. Two 
individuals presented with new non-neurological functional symptoms: one had been seen by 
orthopaedics with chronic back pain and one by nephrology with loin pain. These eight 
included four individuals who remained under paediatric neurology follow up for persisting 
functional symptoms at the time of transition to adult services. Three of these had non-
epileptic seizures alongside epilepsy.  
 
Periods of symptom freedom (from diagnosis of FND to the earlier of either first relapse after 
age 16 or 31st December 2017) ranged from 0 to 20.8 years (median and IQR: 8.3 (4.5 -12.4 
years)). Cox proportional-hazards survival analysis was performed using “documented 
contact with adult medical services after age 16 for functional symptoms” as the dependent 
variable, for the 114 cases over 16 on 31st December 2017. Independent (predictor) variables 
comprised: explanation model, symptom group, age at presentation, sex, delay to diagnosis, 
IDACI score (social deprivation index), involvement of clinical psychology at any time and 
pattern of CAMHS involvement. The results of the model are shown in   
Table 3 and Figure 3. High levels of missingness particularly for explanation model (refer to   
Table 2) mean that the model was fitted on only 79 cases. Prior involvement of CAMHS 
(completed prior to diagnosis of FND) was associated with relapse (HR 3.84; 95%CI 1.25-
11.85, p < 0.05) in the univariable model but this effect was not retained in the multivariable 
model. No variables were significantly associated with relapse in the multivariable model 
(refer to Table 3). . 
  
Discussion 
 
The minimum incidence of FND in childhood is 6 per 100,000 children under 16. This is 
considerably higher than previous estimates of 1-3 per 100,0007,8 and comparable to 
published adult incidence rates23. We suggest our higher rates reflect the frequent “mixed 
picture” situation (also seen in adults1) of functional disorder comorbidity alongside 
coexisting neurological disease, e.g. the combination of non-epileptic seizures with epilepsy. 
The availability of up to five diagnosis fields in the database from which these cases were 
ascertained facilitates recognition of such mixed pictures. This may also underlie our finding 
of a more equal sex distribution than the large excess of females reported in other series6,7. 
Nevertheless, it is important to emphasise that even this figure is very likely to be a severe 
underestimate of FND rates in children as this is a highly selected population of children 
reaching specialist paediatric neurology services often because of diagnostic uncertainty in 
primary and secondary healthcare. Brief, self-limiting symptoms are likely very common in 
children6. We confirm FND rates rise steadily through childhood and adolescence ( 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
Figure 1) (the marked reduction in cases over 16 reflects incomplete ascertainment through 
our paediatric neurology department as in the UK, new presentations in over-16s tend to be 
seen by adult services). Our youngest presentation at age 4 was three years younger than the 
youngest recorded by Ani et al.7 although Kozlowska et al’s youngest case was 38. It seems 
likely that important developmental cognitive milestones (e.g. of self-image24-26) make FND 
more common in older children but are not essential for its occurrence27. 
 
In up to 21 years’ follow up after diagnosis, 26 of the 114 children (23%) who had reached 
16 (and who were thus eligible to present to adult services) had documentation of persisting 
FND of sufficient severity to be recorded in adult medical records. The implied 77% long-
term symptom freedom rate is much greater than typically seen in adult-onset FND9. We 
acknowledge the likelihood of incomplete ascertainment of ongoing FND in adulthood, e.g. if 
sufferers have become disillusioned about likely medical response to ongoing difficulties and 
have decided not to seek support. Additionally, since data protection considerations 
precluded our accessing records of contact with adult mental health services, we cannot 
identify individuals who are only seeing adult mental health services. This view of late 
outcomes is consistent with a literature suggesting that whilst rates of FND symptom 
remission may be high in the short term (>75% at 12 months in Ani et al.’s study7) the longer 
term outlook may be poorer13,14, although still not as bad as adults. Although it is generally 
assumed that paediatric FND outcomes are better than adult outcomes and that this relates to 
symptom duration, neither age at presentation nor duration of symptoms prior to diagnosis 
were associated with long term remission in our results. Adult and paediatric presenters may 
reflect separate populations with distinct risk factors, although the increased frequency with 
age of onset suggests overlap 28. 
 
This study has several unique strengths relative to the existing literature on the topic. The 
available length of follow-up (median 8.3, max 20.8 years from diagnosis of FND) is 
unprecedented. Although not as large as the UK national surveillance study conducted by Ani 
et al7 (n=204), our study is also unique in having full access to medical records for details of 
the pre- and peri-diagnosis periods. We were also able to capture presentations to adult 
medical specialties other than neurology including the Emergency Department. Limitations 
inherent in a retrospective casenote review include the lack of standardised measures and data 
collection protocols. Note that due to the modus operandi of the departmental database it is 
not possible to say much about FND misdiagnosis rates: if in ongoing contact a child initially 
thought to have FND is subsequently realised to have “organic” neurologic disease the 
diagnosis fields in the database are updated. The children in this study are thus those for 
whom a functional diagnosis has remained in place throughout the period of contact with the 
paediatric neurology service.  
 
The survival analysis in Table 3 was performed on a subset of the data (79/114) due to high 
levels of missing data and should be regarded as exploratory in nature only. No reliable 
predictors of long term remission were identified. Although there is some accumulating 
evidence for the effectiveness of psychological treatments for paediatric FND29,30 our data is 
of limited value in adding to this evidence base. Access to CAMHS support in this series was 
at clinician discretion, and given CAMHS resource limitations probably reflected recognition 
of more severe or persistent symptoms. By definition it also implies family willingness to 
entertain psychological approaches to their child’s symptoms. Rates of reported 
psychological co-morbidity at presentation are low (Table 1) but this may reflect previously-
described under-reporting of psychological symptoms in FND31,32 . Although functional 
neurological symptoms almost invariably initially present to paediatricians, successful 
treatment involves collaboration between physical and mental health teams where possible33. 
In a recent survey of 61 Danish paediatricians, only 23% of these practitioners ‘often’ 
referred non-epileptic seizures to mental health teams, and 0% ‘always’ did so32. Thankfully 
our results demonstrate that longterm resolution of symptoms is possible without CAMHS 
involvement. Effective treatments include rehabilitative34 and mental health interventions, 
alongside discouragement of further medical opinion-seeking and investigation.  
 
Paediatric FND is commoner than previous recognised and can have long-term implications. 
Future research should address the importance of prompt recognition and the role of 
explanation models in optimising outcomes32,33,35, particularly as children’s understanding 
will often be mediated through the explanations parents have been given.  
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 Tables 
 
Table 1. Characteristics of study sample 
Characteristic (n= number 
with data available) 
 
Interval between initial 
symptom onset and 
recognition of functional 
aetiology (n=124) 
Range 0-1866 days; 
Median 200 days; 
Inter-quartile range 83-413 days 
Coexisting neurological 
conditions at presentation 
(n=124) 
Active epilepsy 21 
Previous epilepsy 5 
Active migraine 5 
Previous migraine 1 
Cerebral palsy 2 
Other 5 
Nil 85 
Coexisting psychological 
conditions at presentation 
(n=122) 
Anxiety 9 
Learning disability 9 
Depression 3 
ADD + additional features 3 
Autism 2 
OCD 2 
Severe LD 1 
Neglect 1 
Abnormal illness behaviour 1 
Other 2 
Nil 89 
Other neurological diagnoses 
considered prior to recognition 
of FND (n=119) 
Epilepsy 24 
Other 17 (see text) 
Migraine 3 
Nil 75 
 
  
Table 2. Classifications of Explanation Model and Parent Acceptance (see text; cases with 
missing data omitted) 
 
 
Family 
response 
Fully 
accepting 
Largely 
accepting 
Sceptical Hostile Totals 
Explanation 
model 
     
“All 
diagnoses 
excluded” 
11 2 2 2 17 
Ambiguous 7 5 10 1 23 
“Stress-
related” 
4 1 1 3 9 
Explicit 
naming of 
FND or 
equivalent 
7 5 2 3 17 
Totals 29 13 15 9 66 
 
 
  
Table 3. Results of survival analysis. Both the uni- and multivariable models are fitted on 
data from 79 of the 114 subjects over 16 at 31st December 2017 (missing data precluded 
fitting on the full sample). Data are right-censored and left-truncated. The dependent 
‘survival time” variable is the time from sixteenth birthday to the earlier of (i) documented 
functional symptoms in adulthood or (ii) the study census date of 31 December 2017.  Cox 
proportional hazard model. Hazard ratios are shown with 95% confidence intervals in 
parentheses and for non-signficiant results are shown to one decimal place36. Significance 
codes: * = p < 0.1; ** = p < 0.05 
 
  HR (univariable) HR (multivariable)  
Explanation model 
“All diagnoses 
excluded” 
- - 
 
 Ambiguous 1.6 (0.5, 4.7; p=0.410) 1.6 (0.4, 6.2; p=0.515)  
 
Stress 
related/positive 
diagnosis of 
FND 
1.2 (0.4, 3.7; p=0.771) 1.3 (0.3, 5.8; p=0.700) 
 
Symptom group Seizures - -  
 Motor 0.4 (0.1, 1.5; p=0.180) 0.4 (0.1, 2.0; p=0.244)  
 Sensory loss 0.4 (0.1, 1.4; p=0.128) 0.2 (0.04, 1.3; p=0.094) * 
 Pain 0.5 (0.1, 2.2; p=0.365) 0.4 (0.07, 2.2; p=0.293)  
 Other 0.4 (0.1, 1.3; p=0.138) 0.2 (0.03, 1.3; p=0.091) * 
Diagnosis delay Mean (SD) 1.0 (1.0, 1.0; p=0.814) 1.0 (1.0, 1.0; p=0.485)  
Duration of follow-up 
in Paediatric Neurology 
Department 
Mean (SD) 1.0 (1.0, 1.0; p=0.417) 1.0 (1.0, 1.0; p=0.928) 
 
Sex F - -  
 M 0.9 (0.4, 1.9; p=0.693) 0.8 (0.3, 2.7; p=0.749)  
Age Mean (SD) 1.2 (1.0, 1.4; p=0.100) 1.1 (0.8, 1.4; p=0.633)  
IDACI (socioeconomic 
deprivation index) 
score 
Mean (SD) 4.1 (0.5, 35.7; p=0.203) 1.3 (0.0, 40.8; p=0.886) 
 
Early clinical 
psychology 
involvement 
Yes - - 
 
 No 1.0 (0.5, 2.3; p=0.978) 0.6 (0.2, 1.8; p=0.340)  
Involvement of 
CAMHS services 
No record - - 
 
 after 0.6 (0.2, 1.9; p=0.376) 0.2 (0.0, 1.0; p=0.056) * 
 before 
3.84 (1.25, 11.85; 
p=0.019)** 
1.4 (0.2, 12.4; p=0.763) 
 
 spanning 0.6 (0.2, 1.6; p=0.305) 0.5 (0.1, 2.2; p = 0.356)  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
Figure 1. Distribution of age at presentation and gender  
 
 
 
 
Figure 2 Predominant presenting symptom by age 
 
 
 
Figure 3 Survival plot for re-presentation to Adult Medical Services with a diagnosis of FND 
or equivalent (see text). Small figures above the x axis indicate the diminishing number of 
remaining cases contributing to the survival data at increasing time after sixteenth birthday. 
 
 
 
 
 
